StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: UBS Downgrades Merck (MRK) to Neutral
December 13, 2021 3:53 AM
(Updated - December 13, 2021 4:41 AM EST)
UBS analyst Colin Bristow downgraded Merck (NYSE: MRK) from Buy to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Next Articles
Merck's (MRK) VAXNEUVANCE Approved in the EU for Individuals 18 Years of Age and Older
December 15, 2021 6:45 AM
Merck (MRK) Announces FDA Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection
December 13, 2021 5:03 PM
Form 8-K Merck & Co., Inc. For: Dec 10
December 10, 2021 5:25 PM
Form 424B5 Merck & Co., Inc.
December 9, 2021 4:38 PM
